Join Dr. Jim Neuenschwander and the CE Symmetry team on February 17, 2021 at 3:00 PM EST / 2:00 PM CST for an informative session on the role of the biomarker assay procalcitonin in the management of antimicrobial therapy. Dr. Neuenschwander will review procalcitonin assay technology and how to use it to assist in the decision to initiate/not initiate antimicrobial therapy. He will also discuss how to utilize assay levels to make discontinuation or modifications to existing antimicrobial selection. Register for this webinar today at FCEP Procalcitonin Webinar There is no fee to participate.
